Conferences - Results from #11680

EAU 2011 - Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on saturation biopsy scheme - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - This group evaluated the role of magnetic resonance imaging (MRI) in selecting patients for active surveillance (AS).

EAU 2011 - Evaluation of different molecular markers for the detection of minimal residual disease in lymph nodes of patients undergoing radical prostatectomy and extended pelvic lymph node dissection (PLND) - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Although controversial, this group and others have presented data that an extended lymph node dissection for prostate cancer (CaP) improves survival even when the lymph nodes contain no identifiable cancer (pN0).

EAU 2011 - Interest of early confirmatory biopsies and centralized pathological review to select prostate cancer patients for active surveillance - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Selection criteria for active surveillance (AS) for low risk prostate cancer (CaP) are critical to the likelihood of eventual conversion to active treatment.

EAU 2011 - Non-invasive diagnosis of prostate cancer from body fluids using a panel of tumor suppressor genes - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - DNA methylation represents one form of gene alteration that contributes to carcinogenesis.

EAU 2011 - The PCA3 score accurately predicts tumor volume and might help in selecting prostate cancer patients for active surveillance - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - The objective of this study was to assess PCA3 as an additional criterion to select patients with prostate cancer (CaP) for active surveillance (AS).

EAU 2011 - Combining screening and chemoprevention of prostate cancer - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - These investigators combined PSA based screening which has been shown to reduce prostate cancer (CaP) mortality (but identify more Gleason score 6 tumors) and chemoprevention with dutasteride, which reduced CaP detection 22.8% after 4 years in men with a previous negative biopsy (PNBx, due to finding fewer GS 6 tumors).

EAU 2011 - Influence of high dose low molecular weight heparin (LMWH) on blood transfusion and lymphocele rate in open radical prostatectomy - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Patients requiring anticoagulation or antiplatlet therapy undergo bridging with a high dosage of LMWH during open radical prostatectomy (ORP).

EAU 2011 - Open radical prostatectomy (ORP) performed by low volume surgeons predisposes to higher rates of venous thrombosis (VT) and pulmonary embolism (PE) - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - In this presentation, Dr. Jan Schmitges and a group of international collaborators examined the most contemporary VT and PE rates and temporal trends in a large population-based cohort.

EAU 2011 - Results from the Gothenburg randomized prostate cancer screening trial - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - In 1994, 20,000 men born in Sweden between 1930 and 1944, randomly sampled from the population register, were randomized by computer in a 1:1 ratio to either a screening group invited for PSA testing every 2 years (n=10,000) or to a control group not invited (n=10,000).

EAU 2011 - Partial and radical nephrectomy for pT1 renal cell carcinoma: Results of the SATURN project - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Partial nephrectomy is increasingly performed in patients with T1 kidney cancer.

EAU 2011 - Antibiotics and/or alpha blocker agents may decrease the PSA levels before biopsy but not detection rate of prostate cancer - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - The investigators studied the effect of antibiotics and/or alpha-blocker treatment before prostate biopsy on PSA levels and subsequent detection rate of prostate cancer (CaP).

EAU 2011 - Metabolic syndrome and prostate cancer: A possible link to prostate cancer aggressiveness - Session Highlights

VIENNA, AUSTRIA (UroToday.com) -The study objective was to evaluate the association between metabolic syndrome and prostate cancer (CaP) risk and grade among a consecutive series of men undergoing prostate biopsy.

EAU 2011 - Prognostic factors in chromophobe renal cell carcinoma: Results from a retrospective multicenter series - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - The chromophobe subtype is associated with a better prognosis compared with the clear cell subtype. This is true for non-metastatic as well as metastatic tumors.

EAU 2011 - Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favourable MSKCC or ECOG prognostic features - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Cytoreductive nephrectomy should be performed in patients with metastatic kidney cancer who are fit enough for surgery.

EAU 2011 - Periprostatic fat pads harbor lymph nodes and lymph node metastases: Impact on pathological work up - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - This group evaluated the periprostatic fat pad tissue areas from radical prostatectomy (RP) specimens for lymph nodes.

EAU 2011 - Perioperative, oncological and functional outcomes of laparoscopic renal cryoablation and open partial nephrectomy: A matched pair analysis - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Small renal masses are increasingly treated by radio frequency ablation or cryoablation.

EAU 2011 - Nation-wide population-based study on 15-year mortality in prostate cancer according to risk categories in the National Prostate Cancer Register (NPCR) of Sweden - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - The group investigated national data on long term outcomes in contemporary prostate cancer (CaP) according to risk categories by clinical stage, Gleason score, and PSA levels.

EAU 2011 - Complications of the laparoscopic vs. the open techniques in patients with non-metastatic renal cell carcinoma (RCC) treated with partial or radical nephrectomy: A population-based analysis of the United States - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Unfortunately most series on open nephrectomy and partial nephrectomy as well as laparoscopic nephrectomy and partial nephrectomy are non-randomized and retrospective.

EAU 2011 - Multi-institutional analysis of robotic assisted partial nephrectomy for clinical stage 1B renal tumors: Perioperative outcomes in 445 patients - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Partial nephrectomy for T1b tumors is most often performed in an open manner rather than with minimally invasive techniques.

EAU 2011 - Long term results of the International phase III trial BA06 (MRC) 30894 (EORTC) assessing neo-adjuvant CMV chemotherapy for muscle-invasive bladder cancer - Session Highlights

VIENNA, AUSTRIA (UroToday.com) - Neoadjuvant and adjuvant chemotherapy is increasingly discussed in the context of radical cystectomy for urothelial cancer.

Page 585 of 588

Login